Atrium Therapeutics, Inc. Common Stock Financial Flexibility Index
Atrium Therapeutics, Inc. Common Stock financial flexibility index. Atrium Therapeutics, Inc. Common Stock (RNA) has a Financial Flexibility Index of -0.26x as of December 2025. Free cash flow of $-18.37 Million (operating CF $-19.25 Million minus capex $879.00K) represents 0% of total liabilities ($71.07 Million). See RNA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Atrium Therapeutics, Inc. Common Stock (2018–2025)
Financial flexibility index of Atrium Therapeutics, Inc. Common Stock from 2018 to 2025. Historical Financial Flexibility Index trend for Atrium Therapeutics, Inc. Common Stock across 8 annual periods. Explore Atrium Therapeutics, Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.
Atrium Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2018–2025)
Atrium Therapeutics, Inc. Common Stock financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Atrium Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Atrium Therapeutics, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-39.68 Million | $-41.13 Million | $71.07 Million | ▲ +73.6% |
| 2024 | -2.11x | $-293.80 Million | $-300.87 Million | $138.94 Million | ▼ -135.3% |
| 2023 | -0.90x | $-114.84 Million | $-119.06 Million | $127.79 Million | ▲ +59.1% |
| 2022 | -2.20x | $-133.44 Million | $-136.27 Million | $60.73 Million | ▼ -11.4% |
| 2021 | -1.97x | $-91.07 Million | $-94.81 Million | $46.15 Million | ▼ -51.6% |
| 2020 | -1.30x | $-36.02 Million | $-37.12 Million | $27.68 Million | ▼ -7851.3% |
| 2019 | 0.02x | $2.73 Million | $2.49 Million | $162.26 Million | ▲ +107.9% |
| 2018 | -0.21x | $-9.61 Million | $-9.65 Million | $45.11 Million | — |